Citadel's chief people officer leaves the firm as hedge funds battle for talent [Business Insider]
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Business Insider
Become an Insider and start reading now. Have an account? Log in Sjoerd Gehring has left the $67 billion hedge fund Citadel, Business Insider has confirmed. Gehring was the chief people officer at the hedge fund, joining from Apple in late 2024. Hedge funds are battling each other for top trading talent, and recruiters have become stars, too. AI-generated summary Summaries are generated by an AI model trained on Business Insider's articles. AI may make mistakes or provide inaccurate/incomplete information. We're unable to load that answer right now. Please try again. Who is Sjoerd Gehring's successor? How do hedge funds compete for talent? Who are key players in hedge fund hiring? What are Citadel's recruitment strategies? What led to Sjoerd Gehring's departure? Less than two years after leaving tech giant Apple for Ken Griffin's $67 billion hedge fund, Sjoerd Gehring has left Citadel. Loading audio narration... Gehring was the hedge fund's chief people o
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- U.S. judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims [BNN Bloomberg (Canada)]BNN Bloomberg
- CFOs On the Move: Week ending April 17 [Yahoo! Finance]Yahoo! Finance
- U.S. judge rejects Bayer's bid to block Johnson & Johnson prostate cancer drug claims [Yahoo! Finance]Yahoo! Finance
- Barclays Raises Johnson & Johnson (JNJ) Price Target on Strong Pharma Momentum [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson: Why I See Downside Ahead [Seeking Alpha]Seeking Alpha
JNJ
Earnings
- 4/14/26 - Beat
JNJ
Sec Filings
- 4/14/26 - Form 8-K
- 3/26/26 - Form SCHEDULE
- 3/18/26 - Form 13F-HR/A
- JNJ's page on the SEC website